SCHEMBL7474537

SCHEMBL7474537

COc1cc(C(=O)N(C)c2ccc(C)cc2OCCCCN2C(=O)c3ccccc3C2=O)ccc1NC(=O)c1cccc2[nH]c(C)nc12

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
POLB P06746 3/20 0.40
KDM4E B2RXH2 3/20 0.38
HPGD P15428 3/20 0.38
BRPF1 P55201 2/20 0.38
HTT P42858 1/20 0.37
MAPT P10636 2/20 0.36
TP53 P04637 2/20 0.36
BRD4 O60885 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
TSHR P16473 2/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
DHODH Q02127 1/20 0.35
MAPK1 P28482 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7478105 0.88 IRAK4 (0.37) ALDH1A1HPGDHTTMAPTTP53
SCHEMBL7564594 0.88 RXFP1 (0.37) ALDH1A1HPGDHTTMAPTTP53
SCHEMBL7967569 0.88 BRD4 (0.35) ALDH1A1POLBKDM4EHPGDBRPF1
Hydrochloric Acid SCHEMBL7968769 0.87 IRAK4 (0.37) ALDH1A1HPGDMAPTTP53IRAK4
Hydrochloric Acid SCHEMBL7598263 0.87 RXFP1 (0.37) MAPTTP53TSHRIRAK4RXFP1
SCHEMBL7964830 0.87 IRAK4 (0.37) ALDH1A1HPGDMAPTTP53IRAK4
Hydrochloric Acid SCHEMBL7610476 0.87 IRAK4 (0.36) MAPTTP53IRAK4RXFP1DHODH
SCHEMBL7475032 0.86 IRAK4 (0.36) HTTMAPTTP53BRD4SMN1; SMN2
SCHEMBL7425247 0.85 ALDH1A1 (0.43) ALDH1A1POLBKDM4EHPGDBRPF1
SCHEMBL7569093 0.85 AVPR2 (0.38) ALDH1A1POLBKDM4EHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-6207693-B1 Benzamide derivatives having a vasopressin antagonistic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed
EP-0946519-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-06 EP disclosed
WO-1998024771-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-06-11 WO disclosed